Journal of Southern Medical University ›› 2013, Vol. 33 ›› Issue (11): 1565-.
Previous Articles Next Articles
Online:
Published:
Abstract: Objective To analyze the dysregulated genes among the differentially expressed genes in 41 nasopharyngeal biopsysamples and identify their protective transcriptional factors. Methods The differentially expressed gene profiles were obtainedby analyzing both types I and II nasopharyngeal carcinoma (NPC_I and NPC_II, respectively) using EXCEL andBioinformatics tools. The transcriptional factors were further studied only when (1) the difference in the binding sites of thedifferentially expressed genes between NPC_I and NPC_II groups was statistically significant, (2) the expressions of thetranscription factors were correlated with the gene expressions in the samples, and (3) the transcription factors affected at least40% of the expression of the related genes. Results In NPC_I samples, 80 transcription factors were found to be up-regulated,in which RUNX3, GATA3, NR3C1, NRF1, RXRA, SMAD7, TBP, and ZBTB6 were positive factors and HLF and MTF1 werenegative factors, involved in the regulation of the genes in T cell receptor signaling pathway. No eligible transcription factorswere found in association with down-regulated genes in NPC_I compared to NPC_II gene expression profiles. ConclusionsThe over-expressed genes in NPC_I are mainly related to immune responses, and we found 8 positive factors and 2 negativefactors that regulate the genes in T cell receptor signaling pathway. The 10 transcription factors may serve as potentialtherapeutic targets for NPC_I. We failed to identify any transcription factors associated with down-regulated genes in NPC_Irelative to NPC_II possibly as a result of multiple factors that affect the differential gene expressions in NPC_II including thetranscription factors, DNAphosphorylation and modification, chromosome variation and environmental factors.
0 / / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.j-smu.com/EN/
https://www.j-smu.com/EN/Y2013/V33/I11/1565